AI assistant
Oncopeptides Major Shareholding Notification 2021
3091_iss_2021-10-27_f85546d1-8e26-450c-8a2b-f95463e7db59.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Oncopeptides AB
Holder
Fjärde AP-fonden
Instrument
| Instrument | Aktie |
|---|---|
| Before the transaction | |
| Shares | 4,300,000 |
| Voting rights | 4,300,000 |
| Transaction | |
| Reason for major shareholding notification Sell | |
| Date | 25/10/2021 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 2,000,000 |
| Directly held voting rights | 2,000,000 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 2.66 % |
| Directly held voting rights | 2.66 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 2.66 % | 2,000,000 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | 2.66 % | 2,000,000 |
| Group total holdings |
||
| Voting rights Percentage of voting rights 2.66 |
2,000,000 | |
| Published | ||
| 27/10/2021 21:37 Contact |
||
| Name Jannis Kitsakis |
||
| Phone | 070-6038023 Email [email protected] | |
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25